Address And Details
|805 King Farm Blvd , Rockville, MD 20850|
|Fund Manager||Michael Byrum|
|Manager Tenure||14 Years 9 Months|
Strategy And Objective
The Managed Futures Strategy Fund (the Fund ) seeks to achieve absolute returns. The Fund seeks to achieve absolute returns. The Fund intends to invest in multiple proprietary and third-party investment strategies that seek to identify and profit from upcoming movements in any combination of global fixed income, currency, commodity, or equity markets. The strategies maybe quantitative or fundamental in nature, and may use market data and macroeconomic analysis to determine positions. The proprietary strategies may range from broad strategies that seek to provide exposure to all markets to focused strategies that seek to provide exposure to a single asset class, sector, or market.
Net Asset Value
- 1 Week
- 1 Month
- 3 Months
- 1 Yr Return
- 5 Yr Return
Equity Sector Breakdown
|Asset Type||% Of Allocation|
|Total Net Assets||6.05 M|
|Criteria||3 Years||5 Years||10 Years|
|Minimum Initial IRA||$1000|
|Timeframe||Average Annual Current Performance Monthly As Of 11/30/2021||Average Annual Current Performance Quarterly As Of 09/30/2021||Avg Annual Current Performance Monthly As Of 11/30/2021||Avg Annual Current Performance Quarterly As Of 09/30/2021|
|Life Of Fund||
Master The Market with the Help of Our Financial Experts
Recent Articles from TheStreet
Report: Streaming Giants Netflix, Disney+ Likely To Weather Mass Cancellations
Even the biggest streaming services aren’t immune to consumer churn.
Ollie's Stock Drops as Supply-Chain Issues Hurt Q3 Earnings
Ollie's said that supply-chain hurdles continue to hurt the discount retailer in the fourth quarter.
Ulta Beauty Stock Jumps on Earnings Beat, Raised Guidance
Ulta reported record sales and earnings for the third quarter and raised its full-year guidance.
DocuSign Shares Crater on Weaker-Than-Expected Guidance
DocuSign estimates revenue of $557 million to $563 million for the fourth quarter, below the analyst consensus of $575 million.
Moderna Stock Climbs; FDA Seeks Rapid Review of Omicron Vaccines
Moderna climbs on reports U.S. health officials are looking to fast-track omicron-targeted vaccines and drugs.
Stocks Waver as Investors Mull Mixed Jobs Report, Omicron Impact
Stocks waver as investors mull a mixed jobs report, new cases of omicron and Congress keeping the federal government lights on.
Tesla's Musk Unloads $1.01B of Stock; Sales Now Exceed $10B
Electric-vehicle maker Tesla's CEO has parted with more than $10 billion of its stock since Nov. 8.
Didi Global Stock Off as Chinese Ride-Hailing Firm to Delist From NYSE
Didi Global went ahead with a $4.4 billion IPO earlier this year despite pressure from Chinese officials not to do so.